Projects include:Leading the process to determine the viability of a new cancer drug; aligning all aspects in preparation for clinical trials. Facilitating the strategic visioning process with Canadian Cancer Research Alliance to strengthen the future-focus of the organisation. Supporting the development of a new research strategy for the Heart and Stroke Foundation (in collaboration with Batleur Enterprises). Playing an advisory role to strengthen the implementation of the Canadian Cancer Trials Group’s strategic plan.Leading the comprehensive strategic planning process for Canadian Cancer Trials Group to establish a road-map for the next five years. Providing strategic planning and implementation support to the Canadian Association of Provincial Cancer Agencies (CAPCA). Facilitating the development of a pan-Canadian pancreatic cancer research strategy. Supporting the development of a Canadian stakeholder engagement strategy for an international public health organization (in collaboration with Global Health Systems).Conducting a feasibility study which assessed the timing and opportunities to create a research agenda for pancreatic cancer in Canada. Developing a brand strategy for a start-up, non-profit organization (confidential client).Designing and executing a Strategic Environmental Analysis (SEA) for Grand Challenges Canada.Developing an organisational structure to address the strategic, operational and quality aspects of delivering oncology services in the Juravinski Cancer Centre and across the Local Health Integration Network.Designing a stakeholder analysis based on industry standards for the Public Health Agency of Canada. Contributing to the Evaluation of the Canadian Cancer Clinical Trials System for the Canadian Cancer Research Alliance.Contributing to the development of a strategy and evaluation framework for a translational research network in neuroscience.

Led the initial 3-years of implementation of the NCIC 10-year strategic plan, reported to Executive Director and CEO, member of Senior Management Team• Contributed to the NCIC – CCS strategic capability through the creation of a dedicated planning department with core competencies in project management, competitive intelligence, programme evaluation, risk management, governance, strategic and operational planning• Developed and championed the implementation of new standard operating procedures and reporting mechanisms (e.g. project management, annual operating, cross-functional teams, etc.)• Provided senior staff leadership and support to the NCIC governance review producing a new governance framework based on a policy-orientation• Led application of Enterprise Risk Management to NCIC and CCSs research partnerships• Designed and led nation-wide priority-setting process to identify new strategic priorities in Health Economics, Services, Policy and Ethics (HESPE), cancer prevention and survivorship research• Co-Chaired the planning and due-diligence process (with the Director of Research Programs), to create a new Centre for Cancer Research in HESPE in partnership with two provincial cancer agencies• Consultant to the Strategic Planning Working Group, Dalhousie Medical School• Supported the development of a major gifts fundraising strategy (case for support for cancer research• Co-Chaired the Strategic Planning Working Group to create a new strategic plan for the CCS-funded Centre for Behavioral Research and Programme Evaluation (at the University of Waterloo)

• As consultant to the Board of Directors, facilitated the development of “NCIC 2015: Driving Excellent Research to Improve Cancer Control”, a new ten-year strategy for the National Cancer Institute of Canada (Toronto, Canada).• Supported development of the Canadian Diabetes Association new 5-year research strategy (Toronto, Canada)• Completed Strategic Policy Analysis of Prenatal Genetic Testing and Screening for the Roeher Institute (Toronto, Canada)• Contributed to the Present and Future of Acute Coronary Syndrome; a qualitative study based on interviews with 25 experts for Wood Mackenzie Ltd (Boston, Mass).• Contributed to the Present and Future of Managed Care in the United States; a qualitative study based on interviews with 25 experts for Wood Mackenzie Ltd (Boston, Mass).• Designed and executed a qualitative study for Heart and Stroke Foundation of Ontario and Batleur Enterprises Ltd. on the current status and future of health promotion. • Developed strategy implementation plan, financial forecasts and evaluation framework for V20/20 Phase II for Heart and Stroke Foundation of Ontario. • Completed Future of Cancer Care; qualitative study for Nervewire, Ltd. (Boston, Mass.)• Working with Foundation Management developed and implemented a dissemination and publication plan for the Vision 2020 Research Strategy

Founded consulting practice, which successfully competed against Andersen, McKinsey, KPMG etc for North American/European clients in need of customized, content-based strategy, analytic work and capacity building. Managed core staff (12), supplemented by research network model comprising experts across diverse fields (medical specialties, economic, informatics, etc) For Non-Profits, Private Foundations and Government Departments:• Directed research, analysis and strategic development of Vision 20/20 for the Heart and Stroke Foundation of Ontario. Resulted in new research strategy, “Creating Movement along the Value Chain.” • Completed Int'l HIV Expenditures Comparison (IHEC): Comparing HIV Prevention Expenditures, Strategies and Policies in Five OECD Countries for Canadian Policy Research Networks (CPRN) and Health Canada.• Contributed epidemiology and natural history chapters to the Costs of HCV for the Hygeia Ltd. and Health Canada• Completed Disability and the Federal Income Tax Act for the Canadian Association for Community Living• Completed Economic Competitiveness and Quality of Life in City Regions for Human Resources and Development Canada (HRDC)For Global Pharma, Medical Device and Biotech Companies:• Completed, “The leading Edge: Improving Early Commercial Assessment”, a global benchmarking study of 12 pharma and biotech firms. • Supported the development and testing of a multi-attribute decision model for assessing commercial value of drug compounds• Completed commercial assessment of drug compounds in bone metabolism and endocrine system to support “go-no go” decision points in drug R &D process • Completed global pricing and reimbursement study on the treatment of atopic dermatitis• Evaluated the cost-effectiveness of Sustiva (efavirenz) for Dupont Pharma• Assessed the impact of the Glaxo Smithkline merger on the respiratory market• Completed Sharing for Success; a knowledge management study for a major global pharma company.

Principal and sole proprietor of research and consulting practice specializing in health economics, public policy and disability-related issues • Developed protocol, co-directed research and writing of The Economic Burden of HIV/AIDS in Canada (1998) for CPRN and Health Canada. Analytic framework included epidemiologic/economic modeling. • Contributed (as consultant to Federal Task Force on Disability Issues) sections on Federal Income Tax Reform and the Costs of Health and Disability Borne by Employers and The Tax Treatment of Savings and Investment for the Purposes of Providing for Future Health or Disability Related Costs for Final report, Equal Citizenship for Canadians with Disabilities: the Will to Act (1996) • Developed technical analysis and prepared Federal Income Tax Reform and the Costs of Disability Supports for Canadian Association of Community Living• Project Manager, National HIV Income Security Project-Phase 2 for the Canadian AIDS Society (1995-96). A two-year, multi-disciplinary policy research and development initiative focusing on provincial social assistance, Canadian Pension Plan Disability Benefits, federal Income Tax Act, housing, and private insurance. • Developed strategic plan/designed research protocols for a national research program on cost-effectiveness of HIV prevention for CPRN and Health Canada • Member of Advisory Committee and consultant to the management team of the National HIV/AIDS Economics Initiative.• Provided analysis and advice on reimbursement potential for a biotech innovation in diabetic wound care to Smith and Nephew Canada with a focus on Veterans Affairs (Veteran’s Healthcare) , Medical Services Branch (Aboriginal Healthcare) and correctional facility health care• Developed a reimbursement business case from a public payer perspective for Polymerase Chain Reaction (PCR) technology for Roche Diagnostics